CNTX

NASDAQStock

Context Therapeutics Inc.

$3.33+0.24 (+7.93%)

52-Week Range

$0.55

$3.17

Key Stats

Market Cap

306.4M

P/E Ratio

—

Dividend Yield

—

Beta

1.97

Volume

1.5M

Avg Volume

938.5K

Performance

+34.35%

+173.45%

+264.47%

YTD

+99.35%

+267.20%

+355.75%

-39.41%

Price Chart

ETF Exposure

CNTX is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
AVSC	Avantis U.S. Small Cap Equity ETF	0.01%	41,319	$128K	$2.36B	0.25%
VXF	Vanguard Extended Market ETF	0.00%	520,898	$1.4M	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	138	$489	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	4,945	$17K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	23	$84	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	2,815,486	$7.3M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	14,808	$52K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,276	$5K	$1.29B	0.17%

About CNTX ETF Exposure

Context Therapeutics Inc. (CNTX) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 306.4M, CNTX is a widely held institutional stock. The stock currently trades at $3.33. Investors can gain exposure to CNTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CNTX, sorted by portfolio weight.